This article is more than 5 years old. Information may no longer be current.

NxStage sees 13% increase in revenue from sales of its home hemodialysis machine

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

NxStage Medical Inc. reported a 13% increase in revenue for the second quarter of 2014, exceeding the top end of its guidance range. The increase in revenue was driven by strong sales of its System One hemodialysis machine for the home and critical care markets. Home revenue increased 18% to $38.5 million for the second quarter of 2014 compared with 2013. Critical care revenue increased 15% to $12.4 million compared with revenue of $10.8 million for the second quarter of 2013. In-center  dialysis revenue was $21 million for the second quarter of 2014 compared with revenue of $21.2 million for the same quarter in 2013.